Search research articles
Contact Us
Filters
Showing results (1-10 of 435) with videos related to
Page
of 44
Sort By:
Annals of Internal Medicine
|
November 5, 2019
Comparative Modeling to Inform Health Policy Decisions: A Step Forward
David D Kim, Peter J Neumann
JAMA
|
April 18, 2023
Cost-effectiveness Thresholds Used by Study Authors, 1990-2021
Peter J Neumann, David D Kim
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 7, 2023
Author Reply
David D Kim, Peter J Neumann
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 10, 2022
A Systematic Review of Economic Evaluations of COVID-19 Interventions: Considerations of Non-Health Impacts and Distributional Issues
Meghan I Podolsky, Isabel Present, Peter J Neumann, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 31, 2020
Measuring "Fearonomic Effects" in Valuing Therapies: An Application to COVID-19 in China
Siyu Ma, David D Kim, Joshua T Cohen, et al.
BMJ Global Health
|
June 11, 2019
Taking stock of cost-effectiveness analysis of healthcare in China
Thomas Butt, Gordon G Liu, David D Kim, et al.
Health Affairs (Project Hope)
|
November 19, 2020
Consideration Of Value-Based Pricing For Treatments And Vaccines Is Important, Even In The COVID-19 Pandemic
Peter J Neumann, Joshua T Cohen, David D Kim, et al.
BMJ Global Health
|
March 6, 2020
Are low and middle-income countries prioritising high-value healthcare interventions?
Ashley A Leech, David D Kim, Joshua T Cohen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 15, 2018
Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies
Ashley A Leech, David D Kim, Joshua T Cohen, et al.
The American Journal of Managed Care
|
September 15, 2020
Crisis into opportunity: can COVID-19 help set a path to improved health care efficiency?
David D Kim, Daniel A Ollendorf, Peter J Neumann, et al.
Page
of 44
Search research articles
Search
Showing results (1-10 of 435) with videos related to
Sort By:
Page
of 44
Annals of Internal Medicine
|
November 5, 2019
Comparative Modeling to Inform Health Policy Decisions: A Step Forward
David D Kim, Peter J Neumann
JAMA
|
April 18, 2023
Cost-effectiveness Thresholds Used by Study Authors, 1990-2021
Peter J Neumann, David D Kim
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 7, 2023
Author Reply
David D Kim, Peter J Neumann
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 10, 2022
A Systematic Review of Economic Evaluations of COVID-19 Interventions: Considerations of Non-Health Impacts and Distributional Issues
Meghan I Podolsky, Isabel Present, Peter J Neumann, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 31, 2020
Measuring "Fearonomic Effects" in Valuing Therapies: An Application to COVID-19 in China
Siyu Ma, David D Kim, Joshua T Cohen, et al.
BMJ Global Health
|
June 11, 2019
Taking stock of cost-effectiveness analysis of healthcare in China
Thomas Butt, Gordon G Liu, David D Kim, et al.
Health Affairs (Project Hope)
|
November 19, 2020
Consideration Of Value-Based Pricing For Treatments And Vaccines Is Important, Even In The COVID-19 Pandemic
Peter J Neumann, Joshua T Cohen, David D Kim, et al.
BMJ Global Health
|
March 6, 2020
Are low and middle-income countries prioritising high-value healthcare interventions?
Ashley A Leech, David D Kim, Joshua T Cohen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 15, 2018
Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies
Ashley A Leech, David D Kim, Joshua T Cohen, et al.
The American Journal of Managed Care
|
September 15, 2020
Crisis into opportunity: can COVID-19 help set a path to improved health care efficiency?
David D Kim, Daniel A Ollendorf, Peter J Neumann, et al.
Page
of 44